Wealthsource Partners LLC lifted its position in Danaher Co. (NYSE:DHR – Get Rating) by 4.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,274 shares of the conglomerate’s stock after purchasing an additional 53 shares during the period. Wealthsource Partners LLC’s holdings in Danaher were worth $329,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently made changes to their positions in DHR. Bishop Rock Capital L.P. boosted its holdings in Danaher by 13,959.3% in the second quarter. Bishop Rock Capital L.P. now owns 3,955,166 shares of the conglomerate’s stock valued at $15,601,000 after acquiring an additional 3,927,034 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in Danaher by 515.0% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 2,348,688 shares of the conglomerate’s stock valued at $606,643,000 after acquiring an additional 1,966,793 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Danaher by 1.9% in the third quarter. Vanguard Group Inc. now owns 53,690,131 shares of the conglomerate’s stock valued at $13,867,623,000 after acquiring an additional 995,501 shares in the last quarter. Castleview Partners LLC boosted its holdings in Danaher by 23,726.6% in the second quarter. Castleview Partners LLC now owns 791,996 shares of the conglomerate’s stock valued at $3,124,000 after acquiring an additional 788,672 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its holdings in Danaher by 70.1% in the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,376,545 shares of the conglomerate’s stock valued at $348,982,000 after acquiring an additional 567,259 shares in the last quarter. Institutional investors own 77.26% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the stock. Barclays lifted their price target on shares of Danaher from $277.00 to $290.00 and gave the company an “overweight” rating in a report on Tuesday, January 24th. Robert W. Baird lowered their price objective on Danaher from $321.00 to $309.00 in a research report on Wednesday, January 25th. Cowen lowered their price objective on Danaher from $340.00 to $320.00 and set an “outperform” rating for the company in a research report on Wednesday, January 25th. Credit Suisse Group lowered Danaher from an “outperform” rating to a “neutral” rating and lowered their price objective for the company from $315.00 to $300.00 in a research report on Thursday, January 5th. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on Danaher in a research report on Tuesday, December 13th. They set a “buy” rating and a $310.00 price objective for the company. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $310.29.
Insiders Place Their Bets
Danaher Price Performance
Shares of NYSE:DHR opened at $244.85 on Wednesday. Danaher Co. has a fifty-two week low of $233.71 and a fifty-two week high of $303.82. The business has a 50-day simple moving average of $259.27 and a two-hundred day simple moving average of $262.87. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.52 and a current ratio of 1.89. The firm has a market cap of $178.39 billion, a price-to-earnings ratio of 25.37, a price-to-earnings-growth ratio of 1.97 and a beta of 0.80.
Danaher (NYSE:DHR – Get Rating) last issued its earnings results on Tuesday, January 24th. The conglomerate reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.46 by $0.41. Danaher had a return on equity of 17.97% and a net margin of 22.91%. The business had revenue of $8.37 billion during the quarter, compared to analyst estimates of $7.90 billion. During the same quarter in the previous year, the firm earned $2.69 EPS. Danaher’s revenue was up 2.7% on a year-over-year basis. On average, analysts expect that Danaher Co. will post 10.14 earnings per share for the current year.
Danaher Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, March 31st will be given a $0.27 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.25. The ex-dividend date is Thursday, March 30th. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s payout ratio is 10.36%.
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services.
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Get Rating).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.